Clinical Trial Update: A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD) is currently recruiting to assess safety and to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GenSci134

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Safety, Tolerability | Phase 1 | Status: RECRUITING